News

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.
President Donald Trump's new European tariffs may spell bad news for Novo Nordisk, maker of Ozempic and Wegovy. As Axios reports, the 15 percent tariffs on goods imported into the United States from ...
Catherine and Sean Lowe emphasized there is a "healthier route" than Ozempic while speaking to Fox News Digital about their healthy habits.
A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic and Wegovy, were linked to a 33% lower risk of dementia, among other health benefits. Dr. Archina Sadhu, ...
Trump’s trade deal with the E.U. may lead to higher prices for brand-name drugs in the U.S., including the blockbuster ...